GeneFerm Biotechnology Co., Ltd. (TPEX:1796)

GeneFerm Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	173.23	280.26	122.45	120.15	100.69	539.61
Cash & Short-Term Investments	223.23	280.26	122.45	120.15	100.69	539.61
Cash Growth	-18.96%	128.88%	1.91%	19.33%	-81.34%	55.05%
Accounts Receivable	92.65	97.93	101.56	117.6	120.98	104.66
Other Receivables	2.55	15.83	15.22	0.15	0.46	0.24
Receivables	95.19	113.76	116.78	117.75	121.44	104.9
Inventory	207.42	190.23	165.87	155.43	142.61	114.83
Prepaid Expenses	9.47	-	-	3.8	8.81	5.84
Other Current Assets	-	11.23	6.87	-	-	-
Total Current Assets	535.31	595.48	411.97	397.13	373.54	765.18
Property, Plant & Equipment	654.06	663.58	708.46	761.95	734.28	510.39
Other Intangible Assets	0.76	1.16	1.7	2.02	1.1	1.4
Long-Term Deferred Tax Assets	11.53	9.88	14.37	8.87	8.66	7.7
Other Long-Term Assets	13.45	10.55	9.99	5.41	72.05	32.22
Total Assets	1,215	1,281	1,146	1,175	1,190	1,317

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	14.7	16.15	23.77	33.2	49.93	39.08
Accrued Expenses	-	54.28	46.71	58.39	51.9	40.95
Short-Term Debt	-	-	-	40	45	-
Current Portion of Long-Term Debt	-	33.16	24.43	5.25	26	308.65
Current Portion of Leases	8.71	6.26	5.42	6.04	5.97	5.19
Current Income Taxes Payable	-	1.82	-	19.01	10.28	13.42
Current Unearned Revenue	16.46	23.95	12.49	5.78	7.63	8.29
Other Current Liabilities	107.53	23.04	21.43	22.18	42.52	15.6
Total Current Liabilities	147.4	158.64	134.26	189.86	239.22	431.18
Long-Term Debt	180.51	205.38	126.54	-	5.25	31.25
Long-Term Leases	85.78	79.44	78.53	76.15	98.8	92.13
Pension & Post-Retirement Benefits	-	20.53	18.88	16.52	15.59	14.66
Long-Term Deferred Tax Liabilities	-	0.01	0.1	-	-	-
Other Long-Term Liabilities	21.46	0.01	0.01	0.01	0.01	0.01
Total Liabilities	435.15	464	358.31	282.54	358.86	569.22

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	414.6	414.6	414.6	414.6	414.6	407.89
Additional Paid-In Capital	294.34	294.34	294.34	294.34	294.34	270.69
Retained Earnings	72.25	109.84	81.38	186.69	124.26	72.27
Comprehensive Income & Other	-1.22	-2.11	-2.13	-2.79	-2.43	-3.19
Shareholders' Equity	779.96	816.66	788.18	892.84	830.77	747.66
Total Liabilities & Equity	1,215	1,281	1,146	1,175	1,190	1,317

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	275.01	324.23	234.92	127.44	181.02	437.22
Net Cash (Debt)	-51.77	-43.97	-112.47	-7.29	-80.33	102.39
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1.28	-1.06	-2.71	-0.18	-1.89	2.21
Filing Date Shares Outstanding	41.45	41.46	41.46	41.46	41.46	40.79
Total Common Shares Outstanding	41.45	41.46	41.46	41.46	41.46	40.79
Working Capital	387.92	436.85	277.71	207.27	134.32	334
Book Value Per Share	18.82	19.70	19.01	21.53	20.04	18.33
Tangible Book Value	779.2	815.5	786.48	890.82	829.67	746.27
Tangible Book Value Per Share	18.80	19.67	18.97	21.49	20.01	18.30
Land	-	15.44	15.44	15.44	15.44	15.44
Buildings	-	457.57	457.26	260.87	259.44	255.46
Machinery	-	837.21	825.29	822.26	725.62	536.67
Construction In Progress	-	-	-	194.02	184.12	127.34

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error